{"ticker": "ATTO", "overview": {"cik": "2058707", "ticker": "ATTO", "name": "Attovia Therapeutics, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "4/A", "date": "2026-10-08", "title": "Form 4/A", "accession": "0001644888-26-000009", "price_sensitive": false}, {"form": "4/A", "date": "2026-10-08", "title": "Form 4/A", "accession": "0001654907-26-000009", "price_sensitive": false}, {"form": "3/A", "date": "2026-10-08", "title": "Form 3/A", "accession": "0001644888-26-000008", "price_sensitive": false}, {"form": "3/A", "date": "2026-10-08", "title": "Form 3/A", "accession": "0001654907-26-000008", "price_sensitive": false}, {"form": "10-Q", "date": "2026-09-02", "title": "Quarterly report", "accession": "0001193125-26-380228", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-02", "title": "Material event", "accession": "0001193125-26-380215", "price_sensitive": true}, {"form": "144", "date": "2026-08-28", "title": "Notice of proposed sale", "accession": "0000891836-26-000065", "price_sensitive": false}, {"form": "4/A", "date": "2026-08-28", "title": "FORM 4/A", "accession": "0001866174-26-000011", "price_sensitive": false}, {"form": "4/A", "date": "2026-08-28", "title": "FORM 4/A", "accession": "0000886982-26-000522", "price_sensitive": false}, {"form": "4", "date": "2026-08-13", "title": "FORM 4", "accession": "0001866174-26-000009", "price_sensitive": false}, {"form": "4", "date": "2026-08-13", "title": "FORM 4", "accession": "0000886982-26-000495", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-12", "title": "Form SCHEDULE 13G", "accession": "0001172661-26-003341", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-08-11", "title": "Form SCHEDULE 13D", "accession": "0001231919-26-000857", "price_sensitive": false}, {"form": "4", "date": "2026-08-10", "title": "Insider transaction", "accession": "0001193125-26-342487", "price_sensitive": false}, {"form": "4", "date": "2026-08-10", "title": "FORM 4", "accession": "0000905148-26-003548", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-092867", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "Insider transaction", "accession": "0001193125-26-340173", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001231919-26-000838", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001193125-26-338446", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001242882-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0002141590-26-000008", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0002141655-26-000008", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0002142262-26-000006", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001193125-26-338430", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001193125-26-338420", "price_sensitive": false}]}, "description": "Attovia Therapeutics, Inc. trades as ATTO and is registered in the United States, classified under Biological Products, (No Diagnostic Substances) (SIC 2836). Privy Trades holds 12 insider filings for the company, in August 2026. Across those, 5 insiders disclosed 7 open-market purchases totalling $62.94M. The most recent filing on record is dated 12 August 2026.", "exchange": null, "stats": {"buy_n": 7, "buy_sum": 62939984.0, "sell_n": 0, "sell_sum": 0, "net": 62939984.0, "insiders": 5, "first_date": "2026-08-06", "last_date": "2026-08-06"}, "metrics": {"ticker": "ATTO", "has_prices": true, "as_of": "2026-08-27", "last": 21.46, "prev_close": 19.55, "change": 1.9100000000000001, "change_pct": 0.09769820971867008, "session_volume": 137307.0, "vwap_5": 20.37821525649815, "vwap_20": 20.993867481282045, "vwap_60": 20.993867481282045, "vwap_250": 20.993867481282045, "high_52w": 23.24, "low_52w": 18.06, "avg_volume_20": 563056.5294117647, "sessions": 17, "market_cap": null}, "trades": [{"id": "13DG-0001172661-26-003341", "src": "13DG", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Attovia Therapeutics, Inc.", "who_key": "Attovia Therapeutics, Inc.", "role": "Substantial holder \u00b7 13G", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Attovia Therapeutics, Inc. takes a 7.45% passive stake in ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/0001172661-26-003341-index.htm", "trade_date": "2026-08-12", "timestamp": "2026-08-12", "mins": 118962}, {"id": "13DG-0001231919-26-000857", "src": "13DG", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Attovia Therapeutics, Inc.", "who_key": "Attovia Therapeutics, Inc.", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Attovia Therapeutics, Inc. takes a 1.7% activist stake in ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/0001231919-26-000857-index.htm", "trade_date": "2026-08-11", "timestamp": "2026-08-11", "mins": 120402}, {"id": "0001866174-26-000011", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Colin Walsh", "who_key": "WALSH COLIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 10285000.0, "score": 66.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The boardroom is buying: $10.3M of ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000186617426000011/0001866174-26-000011-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0000886982-26-000522", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Goldman Sachs Group Inc", "who_key": "GOLDMAN SACHS GROUP INC", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "action": "BUY", "amount": 10285000.0, "score": 61.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider buys $10.3M of ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2148331/000088698226000522/0000886982-26-000522-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0001866174-26-000009", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Colin Walsh", "who_key": "WALSH COLIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 10285000.0, "score": 66.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders pile into ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000186617426000009/0001866174-26-000009-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0000886982-26-000495", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Goldman Sachs Group Inc", "who_key": "GOLDMAN SACHS GROUP INC", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "action": "BUY", "amount": 10285000.0, "score": 61.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders pile into ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/769993/000088698226000495/0000886982-26-000495-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0001193125-26-342487", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Deep Track Biotechnology Master Fund, Ltd.", "who_key": "Deep Track Biotechnology Master Fund, Ltd.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "10% owner files routine paperwork on ATTO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526342487/0001193125-26-342487-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0000905148-26-003548", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "venBio Global Strategic Fund IV, L.P.", "who_key": "venBio Global Strategic Fund IV, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 6499984.0, "score": 59.8, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000090514826003548/0000905148-26-003548-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0001104659-26-092867", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Redmile Group, LLC", "who_key": "Redmile Group, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 10200000.0, "score": 68.3, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "$10.2M bet: A 10% owner buys ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000110465926092867/0001104659-26-092867-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0001193125-26-340173", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Sanofi", "who_key": "Sanofi", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 5100000.0, "score": 62.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ATTO's biggest backer adds $5.1M", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526340173/0001193125-26-340173-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0001654907-26-000009", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Steven Chan", "who_key": "Chan Steven", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on ATTO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000165490726000009/0001654907-26-000009-index.htm", "trade_date": "2026-08-04", "timestamp": "2026-08-04", "mins": 130482}, {"id": "0001644888-26-000009", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Tao Fu", "who_key": "Fu Tao", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on ATTO \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000164488826000009/0001644888-26-000009-index.htm", "trade_date": "2026-08-04", "timestamp": "2026-08-04", "mins": 130482}], "recent_buys": [{"id": "0001193125-26-340173", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Sanofi", "who_key": "Sanofi", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 5100000.0, "score": 62.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "ATTO's biggest backer adds $5.1M", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526340173/0001193125-26-340173-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0001104659-26-092867", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Redmile Group, LLC", "who_key": "Redmile Group, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 10200000.0, "score": 68.3, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "$10.2M bet: A 10% owner buys ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000110465926092867/0001104659-26-092867-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0000905148-26-003548", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "venBio Global Strategic Fund IV, L.P.", "who_key": "venBio Global Strategic Fund IV, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 6499984.0, "score": 59.8, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000090514826003548/0000905148-26-003548-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0000886982-26-000495", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Goldman Sachs Group Inc", "who_key": "GOLDMAN SACHS GROUP INC", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "action": "BUY", "amount": 10285000.0, "score": 61.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders pile into ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/769993/000088698226000495/0000886982-26-000495-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0001866174-26-000009", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Colin Walsh", "who_key": "WALSH COLIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 10285000.0, "score": 66.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders pile into ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000186617426000009/0001866174-26-000009-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0000886982-26-000522", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Goldman Sachs Group Inc", "who_key": "GOLDMAN SACHS GROUP INC", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "action": "BUY", "amount": 10285000.0, "score": 61.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider buys $10.3M of ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2148331/000088698226000522/0000886982-26-000522-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}, {"id": "0001866174-26-000011", "src": "INSIDERS", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Colin Walsh", "who_key": "WALSH COLIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 10285000.0, "score": 66.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The boardroom is buying: $10.3M of ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000186617426000011/0001866174-26-000011-index.htm", "trade_date": "2026-08-06", "timestamp": "2026-08-06", "mins": 127602}], "institutional": [{"id": "13DG-0001172661-26-003341", "src": "13DG", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Attovia Therapeutics, Inc.", "who_key": "Attovia Therapeutics, Inc.", "role": "Substantial holder \u00b7 13G", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Attovia Therapeutics, Inc. takes a 7.45% passive stake in ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/0001172661-26-003341-index.htm", "trade_date": "2026-08-12", "timestamp": "2026-08-12", "mins": 118962}, {"id": "13DG-0001231919-26-000857", "src": "13DG", "ticker": "ATTO", "cik": "2058707", "company": "Attovia Therapeutics, Inc.", "company_raw": "Attovia Therapeutics, Inc.", "who": "Attovia Therapeutics, Inc.", "who_key": "Attovia Therapeutics, Inc.", "role": "Substantial holder \u00b7 13D", "person_type": "WHALE", "person_label": "Whales", "action": "DISCLOSURE", "amount": 0.0, "score": 0.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Attovia Therapeutics, Inc. takes a 1.7% activist stake in ATTO", "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/0001231919-26-000857-index.htm", "trade_date": "2026-08-11", "timestamp": "2026-08-11", "mins": 120402}], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Colin Walsh", "who_key": "WALSH COLIN", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 20570000.0, "sold": 0, "net": 20570000.0, "trades": 2, "top_score": 66.1, "lean": "buying", "history": [{"action": "BUY", "amount": 10285000.0, "date": "2026-08-06", "score": 66.1, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000186617426000011/0001866174-26-000011-index.htm"}, {"action": "BUY", "amount": 10285000.0, "date": "2026-08-06", "score": 66.1, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000186617426000009/0001866174-26-000009-index.htm"}], "latest": {"action": "BUY", "amount": 10285000.0, "date": "2026-08-06", "score": 66.1, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000186617426000011/0001866174-26-000011-index.htm"}}, {"who": "Goldman Sachs Group Inc", "who_key": "GOLDMAN SACHS GROUP INC", "role": "Insider", "person_type": "INSIDER", "person_label": "Insiders", "bought": 20570000.0, "sold": 0, "net": 20570000.0, "trades": 2, "top_score": 61.1, "lean": "buying", "history": [{"action": "BUY", "amount": 10285000.0, "date": "2026-08-06", "score": 61.1, "source_url": "https://www.sec.gov/Archives/edgar/data/2148331/000088698226000522/0000886982-26-000522-index.htm"}, {"action": "BUY", "amount": 10285000.0, "date": "2026-08-06", "score": 61.1, "source_url": "https://www.sec.gov/Archives/edgar/data/769993/000088698226000495/0000886982-26-000495-index.htm"}], "latest": {"action": "BUY", "amount": 10285000.0, "date": "2026-08-06", "score": 61.1, "source_url": "https://www.sec.gov/Archives/edgar/data/2148331/000088698226000522/0000886982-26-000522-index.htm"}}, {"who": "Redmile Group, LLC", "who_key": "Redmile Group, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 10200000.0, "sold": 0, "net": 10200000.0, "trades": 1, "top_score": 68.3, "lean": "buying", "history": [{"action": "BUY", "amount": 10200000.0, "date": "2026-08-06", "score": 68.3, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000110465926092867/0001104659-26-092867-index.htm"}], "latest": {"action": "BUY", "amount": 10200000.0, "date": "2026-08-06", "score": 68.3, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000110465926092867/0001104659-26-092867-index.htm"}}, {"who": "venBio Global Strategic Fund IV, L.P.", "who_key": "venBio Global Strategic Fund IV, L.P.", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 6499984.0, "sold": 0, "net": 6499984.0, "trades": 1, "top_score": 59.8, "lean": "buying", "history": [{"action": "BUY", "amount": 6499984.0, "date": "2026-08-06", "score": 59.8, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000090514826003548/0000905148-26-003548-index.htm"}], "latest": {"action": "BUY", "amount": 6499984.0, "date": "2026-08-06", "score": 59.8, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000090514826003548/0000905148-26-003548-index.htm"}}, {"who": "Sanofi", "who_key": "Sanofi", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 5100000.0, "sold": 0, "net": 5100000.0, "trades": 1, "top_score": 62.7, "lean": "buying", "history": [{"action": "BUY", "amount": 5100000.0, "date": "2026-08-06", "score": 62.7, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526340173/0001193125-26-340173-index.htm"}], "latest": {"action": "BUY", "amount": 5100000.0, "date": "2026-08-06", "score": 62.7, "source_url": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526340173/0001193125-26-340173-index.htm"}}], "activity": [{"date": "2026-08-06", "net": 62939984.0}], "announcements": [{"form": "4/A", "date": "2026-10-08", "title": "Form 4/A", "accession": "0001644888-26-000009", "price_sensitive": false}, {"form": "4/A", "date": "2026-10-08", "title": "Form 4/A", "accession": "0001654907-26-000009", "price_sensitive": false}, {"form": "3/A", "date": "2026-10-08", "title": "Form 3/A", "accession": "0001644888-26-000008", "price_sensitive": false}, {"form": "3/A", "date": "2026-10-08", "title": "Form 3/A", "accession": "0001654907-26-000008", "price_sensitive": false}, {"form": "10-Q", "date": "2026-09-02", "title": "Quarterly report", "accession": "0001193125-26-380228", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-02", "title": "Material event", "accession": "0001193125-26-380215", "price_sensitive": true}, {"form": "144", "date": "2026-08-28", "title": "Notice of proposed sale", "accession": "0000891836-26-000065", "price_sensitive": false}, {"form": "4/A", "date": "2026-08-28", "title": "FORM 4/A", "accession": "0001866174-26-000011", "price_sensitive": false}, {"form": "4/A", "date": "2026-08-28", "title": "FORM 4/A", "accession": "0000886982-26-000522", "price_sensitive": false}, {"form": "4", "date": "2026-08-13", "title": "FORM 4", "accession": "0001866174-26-000009", "price_sensitive": false}, {"form": "4", "date": "2026-08-13", "title": "FORM 4", "accession": "0000886982-26-000495", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-12", "title": "Form SCHEDULE 13G", "accession": "0001172661-26-003341", "price_sensitive": false}, {"form": "SCHEDULE 13D", "date": "2026-08-11", "title": "Form SCHEDULE 13D", "accession": "0001231919-26-000857", "price_sensitive": false}, {"form": "4", "date": "2026-08-10", "title": "Insider transaction", "accession": "0001193125-26-342487", "price_sensitive": false}, {"form": "4", "date": "2026-08-10", "title": "FORM 4", "accession": "0000905148-26-003548", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-092867", "price_sensitive": false}, {"form": "4", "date": "2026-08-07", "title": "Insider transaction", "accession": "0001193125-26-340173", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001231919-26-000838", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001193125-26-338446", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001242882-26-000004", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0002141590-26-000008", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0002141655-26-000008", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0002142262-26-000006", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001193125-26-338430", "price_sensitive": false}, {"form": "4", "date": "2026-08-06", "title": "Insider transaction", "accession": "0001193125-26-338420", "price_sensitive": false}], "performance": {"ticker": "ATTO", "has_prices": true, "summary": {"n": 7, "avg": 0.05299313052011785, "win_rate": 1.0, "best": 0.05299313052011786, "worst": 0.05299313052011786, "as_of": "2026-08-27"}, "buys": [{"who": "Sanofi", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 5100000.0, "date": "2026-08-06", "score": 62.7, "ref_price": 20.38, "return": 0.05299313052011786}, {"who": "Redmile Group, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 10200000.0, "date": "2026-08-06", "score": 68.3, "ref_price": 20.38, "return": 0.05299313052011786}, {"who": "venBio Global Strategic Fund IV, L.P.", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 6499984.0, "date": "2026-08-06", "score": 59.8, "ref_price": 20.38, "return": 0.05299313052011786}, {"who": "GOLDMAN SACHS GROUP INC", "person_type": "INSIDER", "person_label": "Insiders", "role": "Insider", "amount": 10285000.0, "date": "2026-08-06", "score": 61.1, "ref_price": 20.38, "return": 0.05299313052011786}, {"who": "WALSH COLIN", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 10285000.0, "date": "2026-08-06", "score": 66.1, "ref_price": 20.38, "return": 0.05299313052011786}, {"who": "GOLDMAN SACHS GROUP INC", "person_type": "INSIDER", "person_label": "Insiders", "role": "Insider", "amount": 10285000.0, "date": "2026-08-06", "score": 61.1, "ref_price": 20.38, "return": 0.05299313052011786}, {"who": "WALSH COLIN", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 10285000.0, "date": "2026-08-06", "score": 66.1, "ref_price": 20.38, "return": 0.05299313052011786}]}, "price_series": [{"date": "2026-08-05", "close": 21.9, "volume": 4907295.0}, {"date": "2026-08-06", "close": 20.38, "volume": 413248.0}, {"date": "2026-08-07", "close": 20.17, "volume": 237910.0}, {"date": "2026-08-10", "close": 19.84, "volume": 376598.0}, {"date": "2026-08-11", "close": 18.65, "volume": 475619.0}, {"date": "2026-08-12", "close": 18.06, "volume": 603875.0}, {"date": "2026-08-13", "close": 19.18, "volume": 406528.0}, {"date": "2026-08-14", "close": 19.86, "volume": 98163.0}, {"date": "2026-08-17", "close": 22.71, "volume": 149939.0}, {"date": "2026-08-18", "close": 23.24, "volume": 181573.0}, {"date": "2026-08-19", "close": 22.14, "volume": 364348.0}, {"date": "2026-08-20", "close": 20.21, "volume": 443759.0}, {"date": "2026-08-21", "close": 20.8, "volume": 362171.0}, {"date": "2026-08-24", "close": 20.62, "volume": 81036.0}, {"date": "2026-08-25", "close": 19.31, "volume": 189293.0}, {"date": "2026-08-26", "close": 19.55, "volume": 143299.0}, {"date": "2026-08-27", "close": 21.46, "volume": 137307.0}], "refreshing": true}